These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic factors in children with membranoproliferative glomerulonephritis type I. García-de la Puente S; Orozco-Loza IL; Zaltzman-Girshevich S; de Leon Bojorge B Pediatr Nephrol; 2008 Jun; 23(6):929-35. PubMed ID: 18297315 [TBL] [Abstract][Full Text] [Related]
5. The relation between treatment and prognosis of childhood membranoproliferative glomerulonephritis. Çaltik Yilmaz A; Aydog Ö; Akyüz SG; Bülbül M; Demircin G; Öner A Ren Fail; 2014 Sep; 36(8):1221-5. PubMed ID: 25065413 [TBL] [Abstract][Full Text] [Related]
6. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen. Braun MC; West CD; Strife CF Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311 [TBL] [Abstract][Full Text] [Related]
10. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis. Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034 [TBL] [Abstract][Full Text] [Related]
11. Membranoproliferative glomerulonephritis: the Cincinnati experience--cumulative renal survival from 1957 to 1989. McEnery PT J Pediatr; 1990 May; 116(5):S109-14. PubMed ID: 2329412 [TBL] [Abstract][Full Text] [Related]
12. Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature. Ahmed MS; Wong CF; Shawki H; Kapoor N; Pandya BK Clin Nephrol; 2008 Apr; 69(4):298-301. PubMed ID: 18397706 [TBL] [Abstract][Full Text] [Related]
13. Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy. Bergstein JM; Andreoli SP Pediatr Nephrol; 1995 Jun; 9(3):268-71. PubMed ID: 7632508 [TBL] [Abstract][Full Text] [Related]
14. Treatment of membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Niigata Research Group of Glomerulonephritis and Nephrotic Syndrome. Nishi S; Ueno M; Shimada H; Oosawa Y; Iino N; Iguchi S; Karasawa R; In H; Kawashima S; Saito N; Imai N; Saito K; Suzuki S; Arakawa M; Gejyo F Intern Med; 2000 Oct; 39(10):788-93. PubMed ID: 11030201 [TBL] [Abstract][Full Text] [Related]
16. Remission of resistant MPGN type I with mycophenolate mofetil and steroids. De S; Al-Nabhani D; Thorner P; Cattran D; Piscione TD; Licht C Pediatr Nephrol; 2009 Mar; 24(3):597-600. PubMed ID: 18972137 [TBL] [Abstract][Full Text] [Related]
17. Renal survival in membranoproliferative glomerulonephritis (MPGN): role of long-term treatment with non-steroid anti-inflammatory drugs (NSAID). Lagrue G; Laurent J; Belghiti D Int Urol Nephrol; 1988; 20(6):669-77. PubMed ID: 3229937 [TBL] [Abstract][Full Text] [Related]
18. Idiopathic membranoproliferative glomerulonephritis in Japanese children. Iitaka K; Ishidate T; Hojo M; Kuwao S; Kasai N; Sakai T Pediatr Nephrol; 1995 Jun; 9(3):272-7. PubMed ID: 7632509 [TBL] [Abstract][Full Text] [Related]
19. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin. Bazzi C; Petrini C; Rizza V; Arrigo G; Beltrame A; D'Amico G Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570 [TBL] [Abstract][Full Text] [Related]
20. Re-evaluation of the classification system for membranoproliferative glomerulonephritis. Lu Y; Shen P; Li X; Xu Y; Pan X; Wang W; Chen X; Zhang W; Ren H; Chen N Contrib Nephrol; 2013; 181():175-84. PubMed ID: 23689579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]